Yusuf TURKMEN, Naci BABAT

The First Three Years of Ablation Therapy in Cardiac Arrhythmias: Single Centre Experience

Improvements in both evaluation of intracardiac signals and molecular data yielded an easy understanding of complex cardiac arrhythmias and channelopathies in last years. However, the mentioned techniques are not applicable by all health providers because of high costs, requirement of well-educated team members, and the most importantly the presence of long learning curve for cardiologists In this article, the catheter ablation of arrhythmias in the Van Yuzuncu Yil University Department of Cardiology in last three years will be reviewed. Intracardiac signals were filtered at 20-500 Hz, amplification gains were 10-80 mm/mV. All signals displayed and acquired on an electrophysiological recording system (EP-TRACER 2 system, Schwarzer Cardiotek, Germany). All types of arrhythmias such as atrioventricular nodal reentry tachycardia, atrioventricular reentry tachycardia, atrial flutter, atrial tachycardias, atrial fibrillation, premature ventricular contractions, and ventricular tachycardias were ablated according to the latest quidelines and techniques. A total of 430 patients were screened in this trial. The success rate in the ablation of atrioventricular nodal reentry tachycardia, atrioventricular reentry tachycardia, atrail flutter, atrial tachycardias, atrial fibrillation, premature ventricular contractions, and ventricular tachycardias was 100%, 88.2%, 88.8%, 72.2%, 100%, 73.9%, and 87.5% respectively. There was only one death among 430 ablation procedures in our centre and the reason of death was not clear because of patient’s other co-morbidities. Otherwise, our success and complication rates were similar with the results of most advanced centres in all around of the world.

PDF

___

1. Intracardiac electrograms and sensing test signals: electrophysiological, physical, and technical considerations. Irnich W. Pacing Clin Electrophysiol 1985; 8: 870-888.

2. A novel method for nonfluoroscopic catheterbased electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Gepstein L, Hayam G, Ben-Haim SA. Circulation 1997; 95: 1611-1622.

3. Recent advances in cardiac mapping system. Schmitt C, Ndrepepa G, Deisenhofer I, Schneider M. Curr Cardiol Resp 1999; 1: 149- 156.

4. On the use of CartoSound for left atrial navigation. Schwartzman D, Zhong H. J Cardiovasc Electrophysiol 2010; 21: 656-664.

5. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. Natale A, Newby KH, Pisano E, Leonelli F, Fanelli R, Potenza D, Beheiry S, Tomassoni G. J Am Coll Cardiol 2000; 35: 1898-1904.

6. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640.

7. Martirosyan M, Kiss A, Nagy-Balo E, et al. Learning curve in circular multipolar phased radifrequency ablation of atrial fibrillation. Cardiol J 2015; 22: 260-266.

8. Jastrzebski M, Moskal P, Pitak M, et al. Contemporary outcomes of catheter ablation of accessory pathways: complications and learning curve. Kardiol Pol 2017; 75: 804-810.

9. Holmqvist F, Kesek M, Englund A, et al. A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. Eur Heart J 2019; 40: 820-830.

10. Skanes AC, Dubuc M, Klein GJ, et al. Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation 2000; 102: 2856-2860.

11. Khairy P, Novak PG, Guerra PG, et al. Cryothermal slow pathway modification for atrioventricular nodal reentrant tachycardia. Europace 2007; 9: 909-914.

12. Bastani H, Schwieler J, Insulander P, et al. Acute and long-term outcome of cryoablation therapy of typical atrioventricular nodal reentrant tachycardia. Europace 2009; 11: 1077-1082.

13. Friedman PL, Dubuc M, Green MS, et al. Catheter cryoablation of supraventricular tachycardia: results of the multicenter prospective ―frosty‖ trial. Heart Rhythm 2004; 1: 129-138.

14. Estner HL, Ndrepepa G, Dong J, et al. Acute and long-term results of slow pathway ablation in patients with atrioventricular nodal reentrant tachycardia—an analysis of the predictive factors for arrhythmia recurrence. Pacing Clin Electrophysiol 2005; 28: 102-110.

15. Clague JR, Dagres N, Kottkamp H, Breithardt G, Borggrefe M. Targeting the slow pathway for atrioventricular nodal reentrant tachycardia: initial results and long-term follow-up in 379 consecutive patients. Eur Heart J 2001; 22: 82-88.

16. Insulander P, Bastani H, Braunschweig F, et al. Cryoablation of substrates adjacent to the atrioventricular node: acute and long-term safety of 1303 ablation procedures. Europace 2014; 16: 271-276.

17. Sharma AD, Klein GJ, Guiraudon GM, Milstein S. Atrial fibrillation in patients with Wolff–Parkinson–White syndrome: incidence after surgical ablation of the accessory pathway. Circulation 1985; 72: 161-169.

18. Campbell RW, Smith RA, Gallagher JJ, Pritchett EL, Wallace AG. Atrial fibrillation in the preexcitation syndrome. Am J Cardiol 1977; 40: 514-520.

19. Yamane T, Jaïs P, Shah DC, et al. Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation. Circulation 2000; 102: 2565-2568.

20. Martins RP, Nicolas A, Galand V, et al. The challenging right inferior pulmonary vein: A systemic approach for successful cryballoon ablation. Arch Cardiovasc Dis 2019; 112: 502- 511.